Genetic models, such as mice with mutations in amyloid precursor protein (APP), presenilin-1 (PS1), or PDGF-B genes, replicate Alzheimer’s disease pathology and pericyte deficiency, leading to sustained BBB disruption [6,7]. The gene discussed is APP; the disease is Alzheimer disease.